Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $33,315 | 5 | 80.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,167 | 1 | 12.4% |
| Travel and Lodging | $2,752 | 14 | 6.6% |
| Food and Beverage | $351.33 | 10 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca UK Limited | $29,671 | 4 | $0 (2018) |
| TESARO, Inc. | $6,721 | 11 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $2,640 | 5 | $0 (2017) |
| AbbVie Inc. | $1,300 | 1 | $0 (2021) |
| Celgene Corporation | $730.48 | 1 | $0 (2017) |
| Eli Lilly and Company | $423.70 | 7 | $0 (2019) |
| PFIZER INC. | $99.39 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $1,300 | 1 | AbbVie Inc. ($1,300) |
| 2019 | $423.70 | 7 | Eli Lilly and Company ($423.70) |
| 2018 | $26,065 | 11 | AstraZeneca UK Limited ($19,672) |
| 2017 | $13,797 | 11 | AstraZeneca UK Limited ($9,999) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/16/2021 | AbbVie Inc. | — | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| 12/09/2019 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $45.00 | General |
| 12/09/2019 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $9.45 | General |
| 12/09/2019 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $4.36 | General |
| 08/07/2019 | Eli Lilly and Company | — | Travel and Lodging | Cash or cash equivalent | $48.00 | General |
| 06/19/2019 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $80.64 | General |
| 06/18/2019 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $155.61 | General |
| 06/18/2019 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $80.64 | General |
| 10/29/2018 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| 10/29/2018 | AstraZeneca UK Limited | — | Travel and Lodging | Cash or cash equivalent | $72.00 | General |
| 07/20/2018 | AstraZeneca UK Limited | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $9,600.00 | General |
| Category: Oncology | ||||||
| 05/03/2018 | TESARO, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,166.99 | General |
| 05/03/2018 | TESARO, Inc. | — | Travel and Lodging | In-kind items and services | $217.01 | General |
| 03/16/2018 | TESARO, Inc. | — | Travel and Lodging | In-kind items and services | $338.25 | General |
| 03/15/2018 | TESARO, Inc. | — | Travel and Lodging | In-kind items and services | $103.30 | General |
| 03/15/2018 | TESARO, Inc. | — | Travel and Lodging | In-kind items and services | $51.65 | General |
| 03/15/2018 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: ONCOLOGY | ||||||
| 02/27/2018 | TESARO, Inc. | — | Travel and Lodging | In-kind items and services | $474.55 | General |
| 02/27/2018 | TESARO, Inc. | — | Travel and Lodging | In-kind items and services | $27.00 | General |
| 08/31/2017 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $9,999.12 | General |
| 06/26/2017 | Celgene Corporation | — | Travel and Lodging | In-kind items and services | $730.48 | General |
| 06/23/2017 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $2,416.00 | General |
| Category: Oncology | ||||||
| 06/12/2017 | TESARO, Inc. | ZEJULA (Drug) | Travel and Lodging | In-kind items and services | $273.67 | General |
| Category: ONCOLOGY | ||||||
| 06/12/2017 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: ONCOLOGY | ||||||
| 06/04/2017 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $34.80 | General |
| Category: ONCOLOGY | ||||||
About Gordon Mills, MD, PHD
Gordon Mills, MD, PHD is a Gynecologic Oncology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659454957.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Gordon Mills, MD, PHD has received a total of $41,586 in payments from pharmaceutical and medical device companies, with $1,300 received in 2021. These payments were reported across 30 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($33,315).
Practice Information
- Specialty Gynecologic Oncology
- Location Houston, TX
- Active Since 10/23/2006
- Last Updated 07/08/2007
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1659454957
Products in Payments
- LYNPARZA (Drug) $12,044
- ZEJULA (Drug) $342.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in Houston
Robert Coleman, M.d, M.D
Gynecologic Oncology — Payments: $839,472
Maurie Markman, M.d, M.D
Gynecologic Oncology — Payments: $479,163
Dr. Aparna Kamat, M.d, M.D
Gynecologic Oncology — Payments: $234,318
Anil Sood, M.d, M.D
Gynecologic Oncology — Payments: $70,682
Alpa Nick, Md, MD
Gynecologic Oncology — Payments: $40,612
Pamela Soliman, M.d, M.D
Gynecologic Oncology — Payments: $34,839